CDC logo, Safer Healthier People  CDC HomeCDC SearchCDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us






Estra - 1,3,5 (10) - triene - 3,17 - diol (17 - beta) - , 3 - (bis (2 - chloroethyl) carbamate) 17 - (dihydrogenphosphate) , disodium salt

RTECS #: KG7350000

CAS #: 52205-73-9


UPDATE: August 2007 MW: 566.41 MF: C23H32Cl2NO6P•2Na


NOTE:

TABLE OF CONTENTS:
  1. SYNONYMS:
  2. REPRODUCTIVE EFFECTS DATA:
  3. ACUTE TOXICITY DATA:
  4. OTHER MULTIPLE DOSE DATA:
  5. REVIEWS:
  6. NIOSH DOCUMENTATION AND SURVEILLANCE:
  7. REFERENCES:

SYNONYMS:

  1. Emcyt
  2. Estra - 1,3,5 (10) - triene - 3,17 - beta - diol 3 - (bis (2 - chloroethyl) carbamate) 17 - disodium phosphate
  3. Estracyt sodium
  1. Estramustine phosphate sodium
  2. Estramustine phosphate disodium


SKIN AND EYE IRRITATION DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
N/R
N/R N/R N/R


MUTATION DATA AND REFERENCES:

SYSTEM TEST ROUTE/
ORGANISM/
TISSUE
DOSE REFERENCE
N/R N/R N/R N/R


REPRODUCTIVE EFFECTS DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
oral
rat
lowest published toxic dose: 30 mg/kg (60 day male) Reproductive: Paternal effects: Testes, epididymis, sperm duct OYYAA2 20,1211,1980
oral
rat
lowest published toxic dose: 5,500 µg/kg (7-17 day pregnant) Reproductive: Effects on newborn: Behavioral

Reproductive: Effects on newborn: Physical
OYYAA2 20,1219,1980
oral
rat
lowest published toxic dose: 22 mg/kg (7-17 day pregnant) Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)

Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
OYYAA2 20,1219,1980
oral
rat
lowest published toxic dose: 44 mg/kg (7-17 day pregnant) Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth)

Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)

Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
OYYAA2 20,1219,1980
oral
rabbit
lowest published toxic dose: 650 µg/kg (6-18 day pregnant) Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) OYYAA2 21,41,1981
oral
rabbit
lowest published toxic dose: 2,600 µg/kg (6-15 day pregnant) Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) OYYAA2 21,41,1981
oral
rabbit
lowest published toxic dose: 1,300 µg/kg (6-15 day pregnant) Reproductive: Effects on fertility: Other measures of fertility OYYAA2 21,41,1981


TUMORIGENIC DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
N/R
N/R N/R N/R


ACUTE TOXICITY DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
intravenous
mouse
lethal dose (50 percent kill): 380 mg/kg Lung, Thorax, or Respiration: Respiratory depression OYYAA2 20,1141,1980
intravenous
rat
lethal dose (50 percent kill): 208 mg/kg Lung, Thorax, or Respiration: Respiratory depression OYYAA2 20,1141,1980
oral
dog
lethal dose (50 percent kill): >3 gm/kg Gastrointestinal: Changes in structure or function of salivary glands

Gastrointestinal: Hypermotility, diarrhea

Kidney, Ureter, and Bladder: Hematuria
OYYAA2 20,1141,1980
oral
mouse
lethal dose (50 percent kill): >12 gm/kg N/R OYYAA2 20,1141,1980
oral
rat
lethal dose (50 percent kill): 5,400 mg/kg Gastrointestinal: Hypermotility, diarrhea

Kidney, Ureter, and Bladder: Hematuria
OYYAA2 20,1141,1980
oral
rabbit
lethal dose (50 percent kill): 5,655 mg/kg Gastrointestinal: Hypermotility, diarrhea

Kidney, Ureter, and Bladder: Hematuria
OYYAA2 20,1141,1980
subcutaneous
mouse
lethal dose (50 percent kill): 5,200 mg/kg Skin: After systemic exposure: Dermatitis, other

Skin and Appendages: Other: Hair
OYYAA2 20,1141,1980
subcutaneous
rat
lethal dose (50 percent kill): 9 gm/kg Skin: After systemic exposure: Dermatitis, other

Skin and Appendages: Other: Hair
OYYAA2 20,1141,1980


OTHER MULTIPLE DOSE DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
intraperitoneal
mouse
lowest published toxic dose: 500 mg/kg/5 day- intermittent Gastrointestinal: Colon tumors

Tumorigenic: Active as anti-cancer agent
EJCAAH 38,194,2002
oral
dog
lowest published toxic dose: 320 mg/kg/32 day- intermittent Blood: Hemorrhage

Blood: Normocytic anemia

Related to Chronic Data: Changes in uterine weight
OYYAA2 20,1161,1980
oral
monkey
lowest published toxic dose: 1,274 mg/kg/13 week- intermittent Endocrine: Other changes

Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)

Related to Chronic Data: Changes in uterine weight
OYYAA2 20,757,1980
oral
rat
lowest published toxic dose: 3,500 mg/kg/5 week- continuous Liver: Changes in liver weight

Endocrine: Other changes

Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)
OYYAA2 21,211,1981
oral
rat
lowest published toxic dose: 3,640 mg/kg/26 week- continuous Kidney, Ureter, and Bladder: Other changes in urine composition

Endocrine: Other changes

Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)
OYYAA2 21,549,1981


REVIEWS:

ORGANIZATION STANDARD
REFERENCE

TOXICOLOGY REVIEW
ENTOX* -,384,2005


STANDARDS AND REGULATIONS:

ORGANIZATION STANDARD
REFERENCE

N/R N/R N/R


NIOSH DOCUMENTATION AND SURVEILLANCE:

ORGANIZATION STANDARD or SURVEY
REFERENCE

National Occupational Exposure Survey 1983 National Occupational Exposure Survey 1983: Hazard Code: X5435;
Number of Industries 1;
Total Number of Facilities 9;
Number of Occupations 1;
Total Number of Employees Exposed 63;
Total Number of Female Employees Exposed 9


STATUS IN FEDERAL AGENCIES:

ORGANIZATION
REFERENCE

N/R


REFERENCES:

CODEN
REFERENCE

EJCAAH European Journal of Cancer (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1965-
ENTOX* Encyclopedia of Toxicology: Reference Book, Elsevier, 2005
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967-

Used as an antiprostatic agent

FDA-proprietary drug

RTECS Compound Description:
   Tumorigen
   Drug
   Reproductive Effector
   Hormone

Click Here for Additional Information about RTECS

NIOSH Home |  NIOSH Search  |  Site Index  |  Topic List |  Contact Us